TABLE 2

Baseline prevalence of chronic cough

Baseline characteristics	Subjects at risk n	Prevalent chronic cough n	Prevalence % (95% CI)	p-value
Study Population	9824	1073	10.9 (10.3–11.6)
Sex
Male	4099	434	10.6 (9.7–11.6)	0.369
Female	5725	639	11.2 (10.4–12.0)	0.369
Age ≥70 years
No	6118	579	9.5 (8.7–10.2)	<0.001
Yes	3706	494	13.3 (12.3–14.5)
Age <70 years
Male	2640	224	8.5 (7.4–9.6)	0.023
Female	3478	355	10.2 (9.2–11.3)	0.023
Smoking status
Never	3133	268	8.6 (7.6–9.6)	<0.001
Past	4915	475	9.7 (8.9–10.5)
Current	1769	329	18.6 (16.8–20.5)
ACE-inhibitors
Non-users	7987	829	10.4 (9.7–11.1)	<0.001
Users	1837	244	13.3 (11.8–14.9)	<0.001
Obesity
No	6618	679	10.3 (9.5–11.0)	0.154
Yes	2114	240	11.4 (10.0–12.8)	0.154

ACE: angiotensin converting enzyme